The Hemagglutinin A Stem Antibody MEDI8852 Prevents and Controls Disease and Limits Transmission of Pandemic Influenza Viruses

BACKGROUND: MEDI8852 is a novel monoclonal antibody (mAb) that neutralizes both group I and group II influenza A viruses (IAVs) in vitro. We evaluated whether MEDI8852 was effective for prophylaxis and therapy against representative group I (H5N1) and group II (H7N9) pandemic IAVs in mice and ferret...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Paules, Catharine I, Lakdawala, Seema, McAuliffe, Josephine M, Paskel, Myeisha, Vogel, Leatrice, Kallewaard, Nicole L, Zhu, Qing, Subbarao, Kanta
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
Major Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5853468/
https://ncbi.nlm.nih.gov/pubmed/28633457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jix292
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares